SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
499Transplantation. 2005 May 15;79(9):1121-1127. Related Articles, Links Preventkeokalani'nui-5/10/2005
498Alexion Pharmaceuticals Completes Enrollment of its Pivotal Phase III TRIUMPH TrIcebrg-4/12/2005
497Press Release Source: Alexion Pharmaceuticals Researchers Uncover New Clinicalkeokalani'nui-4/5/2005
496J Thorac Cardiovasc Surg. 2005 Feb;129(2):300-6. Related Articles, Links Inckeokalani'nui-3/18/2005
495Wrong board :-) I do worry about symlin potential given diabetics adding a serkrw-3/16/2005
494Amylin Pharmaceuticals Announces FDA Approval of SYMLIN for Insulin-Using Type 2Biotech Jim-3/16/2005
493Alexion Pharmaceuticals Announces Management Change Wednesday March 16, 4:05 pm Icebrg-3/16/2005
492Item 1.01 Entry into a Material Definitive Agreement. On March 9, 2005Icebrg-3/15/2005
491Alexion Pharmaceuticals Appoints Dr. Ruedi E. Waeger to Board of Directors Tuesdkeokalani'nui-3/8/2005
490Pharmacologic C5-complement suppression reduces blood loss during on-pump cardiaIcebrg-3/6/2005
489SAN DIEGO--(BUSINESS WIRE)--Feb. 7, 2005-- Ligand Pharmaceuticals Incorporated (keokalani'nui-2/8/2005
488Ziff files for 6%. ALXN the object of some big, hot money the last 3 weeks. Hakeokalani'nui-2/4/2005
487David Keiser exercised 11.500 options @ USD 2,375 and sold 4.500 of them at 24,5Icebrg-1/31/2005
486CHESHIRE, Conn., Jan. 25 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc.Icebrg-1/25/2005
485Alexion Pharmaceuticals Prices Private Offering of Convertible Senior Notes Wednkeokalani'nui-1/19/2005
484I agree, this is a good housekeeping move by the company. The market doesn'tIcebrg-1/18/2005
483The redemption price of the old will be 102.4-101.643% or thereabouts. The convkeokalani'nui-1/18/2005
482Eculizumab goes to last stage of testing Record-Journal staff CHESHIRE — AlexiIcebrg-1/11/2005
481Alexion Pharmaceuticals Initiates Treatment in SHEPHERD, Its Second Phase III EcIcebrg-1/10/2005
480DJ reports there will be leaps starting Thurs. keokalani'nui-1/5/2005
479Alexion Pharmaceuticals upgraded to "outperform" Wednesday, January 0Icebrg-1/5/2005
478Thanks Ice. I did listen. It sounds like I overreacted to the abstract. "keokalani'nui-12/13/2004
477At the Harris Nesbitt conference a couple of days ago, Dr Bell again stated thatIcebrg-12/12/2004
476ahhhhhhhhh.... I meant 1-4 per million, not %. What???? I was off only by a fakenhott-12/8/2004
475Thanks for reply, kenhott. EOM.keokalani'nui-12/8/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News